Infectious Disease

Top Story

Boo! PQRS, Value Modifier penalties for 2017 sure to scare you

October 25, 2016

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.

On Sept. 26, CMS posted 2017 payment adjustment notices for the Physician Quality Reporting System (PQRS) and Value-Based Payment Modifier (Value Modifier) programs on the CMS Enterprise Portal. For some providers, downward payment adjustments under both programs may be as high as –6% of all Medicare services paid under the Physician Fee Schedule (PFS) in 2017 (–2% for PQRS and –4% for Value Modifier). Providers have until Nov. 30 to submit informal review requests to CMS if they believe they have been incorrectly assessed a negative payment adjustment under either program.

Meeting News

PUNCH CD2: Microbiome drug safely prevents C. difficile recurrence

October 25, 2016
RBX2660, a microbiome-based drug candidate, safely prevented recurrent Clostridium difficile infection after a standard course of antibiotics, according to results from…
Meeting News Coverage

11 pieces of advice from the physician-patient

October 25, 2016
LAS VEGAS — In an emotional lecture at ACG 2016, Philip O. Katz, MD, gave his colleagues a look into what a patient experiences and how to best treat a peer…
FDA News

FDA approves Roche’s cobas MPX test for use with cobas 6800/8800 systems

October 25, 2016
The FDA has approved Roche’s cobas MPX test for use on the cobas 6800 and 8800 systems, according to a news release from the company. The cobas MPX is a nucleic…

Officials say $1.5 billion needed to finish job of polio eradication

October 25, 2016
Finishing the job of eradicating polio will cost an additional $1.5 billion and will require enhanced vaccination and surveillance efforts in hard-to-reach places where…
More News Headlines »

HCV Updates and Case Challenges for the Rapidly Changing Landscape

This activity is supported by an educational grant from Merck & Co., Inc.

In the past few years, significant progress has been made in the treatment of chronic hepatitis C virus (HCV). Highly…
More »

Merck facilities recognized by the ASM as ‘Milestones in Microbiology’ sites

October 23, 2016
The American Society for Microbiology recognized Merck Research Laboratories facilities in Rahway, NJ and West Point…
More »
Discoveries from ASM Microbe: HIV

Discoveries from ASM Microbe: HIV


VIDEO: Regimens for latent TB in patients with HIV have advantages, disadvantages

July 19, 2016
More »